Clinical trial
Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
NCT07281014 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
- Lead sponsor
- Yale University
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- January 27, 2026
- Completion date
- August 31, 2027
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.